Pöyry Oyj: Interim Report 1 January - 31 March 2015

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Pöyry Oyj: Interim Report 1 January - 31 March 2015

PÖYRY PLC         Interim Report 5 May 2015 at 8:30 a.m. EEST

ORDER STOCK AND OPERATING PROFIT INCREASED

HIGHLIGHTS JANUARY - MARCH 2015 

(Figures in brackets, unless otherwise stated, refer to the same period of the previous year.)

  • The Group's order stock at the end of March was EUR 532.2 (540.4) million. The figure improved by EUR 32.2 million from the comparable order stock in 2014, excluding the divestment in Finland in June 2014. Order stock improved clearly from EUR 472.5 million at the end of 2014.  
  • Consolidated net sales were EUR 146.7 (151.3) million. Comparable net sales in 2014 were EUR 140.4 million.  
  • Consolidated operating profit increased to EUR 2.7 (-1.8) million. It was positive in all Business Lines.

KEY FIGURES

  1-3/ 1-3/ Change, 1-12/
Pöyry Group 2015 2014 % 2014
Order stock at the end of period, EUR million 532.2 540.4 -1.5 472.5
Net sales total, EUR million 146.7 151.3 -3.0 571.2
Operating profit/loss, EUR million 2.7 -1.8 n.a. -23.1
Operating margin, % 1.8 -1.2   -4.0
Profit/loss before taxes, EUR million -0.7 -3.0 n.a. -28.0
Earnings per share, basic, EUR -0.01 -0.06 n.a. -0.40
Earnings per share, diluted, EUR -0.01 -0.06 n.a. -0.40
Gearing, % 38.3 44.5   39.1
Return on investment, % 6.4 -2.0   -9.9
Average number of personnel during the period,        
calculated as full time equivalents (FTE) 5,105 5,746 11.2 5,433

All figures and sums have been rounded off from the exact figures, which may lead to minor discrepancies upon addition or subtraction.

ALEXIS FRIES, PRESIDENT AND CEO:

"The first quarter of 2015 marked an encouraging turn in our performance. We have delivered better results in most of our Business Lines and have continued to address various improvement areas. The necessary structural adjustments have been successfully pursued, in Central Europe and Brazil in particular. Our increasing activity rate indicates improving operational efficiency. Our enhanced sales focus, announced earlier, has resulted in good order intake. We shall continue to work along these lines, relentlessly pushing for sales, increasing activity rates and improving project management performance.

Pöyry's comparable net sales in the first quarter of the year increased to EUR 146.7 (140.4) million, excluding the divested business in June 2014. The figure increased in the Energy and Industry Business Groups and remained stable in the Regional Operations and the Management Consulting Business Group.

Consolidated operating profit increased to EUR 2.7 (-1.8) million and was positive in all Business Lines. The figure grew in the Industry Business Group and especially in the Regional Operations due to improved business performance in Europe. Operating profit remained stable in the Energy and Management Consulting Business Groups.

The Group's order prospects remained solid. Comparable order intake increased year-on-year as several mid-sized projects were secured during the period. The figure improved significantly in the Industry Business Group as a result of favourable development in our chemicals and bio-refining business, as well as assignments secured in the pulp and paper sector. Order intake also increased clearly in the Energy Business Group along with projects secured in Asia and Latin America. The figure remained stable in the Management Business Group. However, it decreased clearly in the Regional Operations. Lower volumes were recorded in Latin America, where a large project that was awarded in 2014 affected the comparable figure. In addition, local market development in Brazil remained uncertain amid current political tensions. Volumes in other parts of the Regional Operations, however, improved or remained stable.

Pöyry's comparable order stock was EUR 532.2 (500.0) million. It increased clearly from EUR 472.5 million at the end of 2014. The figure remained stable in the Regional Operations and increased in all other Business Lines. It improved especially in the Industry Business Group, which was consistent with a significantly stronger order intake.

The Group's unallocated costs decreased in line with expectations, as we continued to streamline our cost structures in the global support functions.

No further impact was recorded from past problem projects, which mostly originated from the former Urban Business Group, and that have been communicated in our earlier reports. Their execution continues according to expectations."

The complete January-March 2015 Interim report is enclosed with this company announcement and is available in full on the company's website at www.poyry.com . Investors are advised to review the complete interim report with tables.

PÖYRY PLC

Additional information: Jukka Pahta, CFO tel. +358 10 33 22629

INVITATION TO CONFERENCES TODAY ON 5 MAY 2015

Pöyry's January-March 2015 result will be presented at the following news conferences:

  • A conference for analysts, investors and press will be arranged at 12:00 p.m. Finnish time (EEST) at Restaurant Savoy, Eteläesplanadi 14, Helsinki, Finland. The event will be hosted by Alexis Fries, President and CEO and Jukka Pahta, CFO.  
  • An international conference call and webcast in English will begin at 5:00 p.m. Finnish time. The event will be hosted by Jukka Pahta, CFO.

10:00 a.m. US EDT (New York) 3:00 p.m. BST (London) 4:00 p.m. CEST (Paris)

The webcast may be followed online on the company's website www.poyry.com . A recording will be made available by the next working day on the same website.

To attend the conference call, please dial:

FI: +358 (0)9 2313 9201 SE: +46 (0)8 5052 0110 UK: +44 (0)20 7162 0077 US: +1 334 323 6201 Other countries: +44 (0)20 7162 0077

Conference ID: 952617

Due to the nature of the live webcast, we kindly ask those attending the international conference call and webcast to dial in 5 minutes prior to the start of the event.

Pöyry is an international consulting and engineering company. We serve clients globally across the energy and industrial sectors and provide local services in our core markets. We deliver management consulting and engineering services, underpinned by strong project implementation capability and expertise. Our focus sectors are power generation, transmission & distribution, forest industry, chemicals & biorefining, mining & metals, transportation and water. Pöyry has an extensive local office network employing about 6,000 experts. Pöyry's net sales in 2014 were EUR 571 million and the company's shares are quoted on NASDAQ OMX Helsinki (Pöyry PLC: POY1V).

DISTRIBUTION: NASDAQ OMX Helsinki Major media www.poyry.com

Interim Report 1 January - 31 March 2015 http://hugin.info/120101/R/1918610/686651.pdf

HUG#1918610

Scroll down for more posts ▼

Top 10 Most Recent News Articles

BTQ Technologies Calls Investors for Key Quantum Update

Updated Category News Views 177

You know what's stirring the pot over at BTQ Technologies? A shareholder call coming up soon, and boy, it's got 'eye-opening insights' written all over it. We're talkin' Q3 financial results and, likely, a smattering of future plans on the quantum front, folks. Diving into BTQ's Quantum Vision BTQ Technologies Corp. (NASDAQ: BTQ) isn't just another tech firm banging on...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 194

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 137

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
Ecopetrol Sidesteps Hefty Fines After Investigation Closure

Updated Category News Views 145

Colombian Watchdog Gives Ecopetrol a Pass It's like dodging a bullet in a duel at high noon. The Superintendency of Industry and Commerce (SIC) has finally closed its investigation into Ecopetrol S.A. and its subsidiaries, CENIT and OCENSA, after a probe two years in the making. The stakes were sky-high, folks. We're talkin' about just shy of 530 billion Colombian pesos...

Continue Reading
Microsoft's Cloud Misstep: Recovery Plans in Focus

Updated Category News Views 133

Microsoft's Stumble Puts CIOs on Alert Thursday's Microsoft 365 outage, a wrench in the works for every firm that ties its daily operations to these cloud services, has brought some harsh truths to the table. On November 12, outages hit users hard, preventing access to Exchange Online mailboxes and sending ripples through Teams, SharePoint, Copilot, and Defender. You...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 193

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 197

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 134

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
ManuTech Center Set to Revolutionize Manufacturing Hub

Updated Category News Views 138

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

Continue Reading
HiTHIUM Joins Cambridge to Boost Global Energy Storage

Updated Category News Views 255

HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...

Continue Reading

Top 5 Most Recently Viewed Articles

Kimbell Royalty Partners Engages Investors at Key Conferences

Updated Category News Views 101

Kimbell Royalty Partners to Attend Notable Investor Conferences Kimbell Royalty Partners, LP (NYSE: KRP) is a prominent owner of oil and natural gas mineral and royalty interests. The company proudly manages over 129,000 gross wells across multiple states. In an effort to strengthen investor relations and share its strategic outlook, Kimbell has announced its...

Continue Reading
Karsan's Autonomous Bus Debuts at Efteling Park

Updated Category News Views 72

A Leap Towards Autonomous Mobility What we have here is Karsan breaking new ground again. They've rolled out their Autonomous e-ATAK at Efteling, the famous theme park in the Netherlands. And that's not just any park—it's a place teeming with tourists, a hotspot demanding efficient transport. Yet, these folks aren't just cranking out fancy gadgets for showing off....

Continue Reading
EyePoint Pharmaceuticals Expands Workforce with Stock Options

Updated Category News Views 301

EyePoint Pharmaceuticals Expands Workforce with Stock Options EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a dynamic biopharmaceutical company, is on a mission to enhance the lives of patients facing serious retinal diseases. Recently, the company made a notable announcement regarding the expansion of its team through the granting of non-statutory stock options to new...

Continue Reading
IonQ Shares: Insights Into Their Current Market Performance

Updated Category News Views 204

Overview of IonQ's Current Stock Performance IonQ Inc. IONQ shares have seen a notable decline recently, continuing a downward trend that’s persisted over the last couple of weeks. As the company gears up to announce its second-quarter earnings, investors are closely monitoring the developments, particularly the anticipated shift in stock momentum. Market Sentiment and...

Continue Reading
Exploring the Promising CD47 Inhibitor Drug Market Growth

Updated Category News Views 40

Understanding the CD47 Inhibitor Drug Market Gaining insights into the CD47 inhibitor drug market is crucial for recognizing the changes and advancements in cancer immunotherapy. These drugs play a vital role in the battle against cancer by harnessing the body's immune system to identify and eliminate malignant cells. CD47's Role in Cancer CD47, often referred to as the...

Continue Reading